First ZEVASKYN® commercial patient treatment completed in December -- ZEVASKYN launch momentum building in first quarter 2026 –- $191.4M in ...
The inspection report highlights deficiencies in audit documentation, independence monitoring and compliance with auditing standards. It stresses the need for stronger quality control systems and ...
First ZEVASKYN- commercial patient treatment completed in December - - ZEVASKYN launch momentum building in first quarter 2026 - - $191.4M in cash, cash equivalents and short-term investments as of ...
Last spring, Sioux Falls Housing decided to set aside a portion of Section 8 housing vouchers to help chronically homeless people not only find housing, but keep it. Here's what you need to know.
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry ...
On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating ...
Here are this week’s travel contests! You can win trips & prizes such as Switzerland; a Porsche Macan; $1,000; ...